ICMR refuses using Molnupiravir for COVID treatment, pulmonologists disagree
Dr Bhargava had last week said that Molnupiravir has major safety concerns. He added that WHO and the UK have not included it for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Balram Bhargava
No scientific evidence to support need for booster vaccine dose against COVID, says ICMR chief
According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory…
Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR
Normally the final trial takes about six to nine months
India-Sweden Healthcare Innovation Centre launches ‘Innovation Challenge’
It is an opportunity for start-ups to collaborate with partners on the Innovation Centre platform to help solve some of the…
SII, Gavi and BMGF collaborate for COVID-19 vaccines, SII to price per vaccine dose at Rs 225
Serum Institute of India to produce up to 100 million COVID-19 vaccine doses which will be made available to the 92 countries…
AIIMS Ethics Committee gives nod to human clinical trial of Covaxin
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human…
ICMR-Bharat Biotech to expedite clinical trials of COVID-19 vaccine, plan launch by August 15
Presently, 12 clinical trial sites have been identified and ICMR has asked the institutions to enable subject enrolment by the…